Purpose: To simultaneously assess reproducibility of three MRI transverse relaxation parameters (R 0 2 , R Ã 2 , and R 2 ) for brain tissue oxygenation mapping and to assess changes in these parameters with inhalation of gases that increase and decrease oxygenation, to identify the most sensitive parameter for imaging brain oxygenation. Materials and Methods: Forty-eight healthy subjects (25 male, ages 35 6 8 years) were scanned at 3.0 Tesla, each with one of four gases (mildly and strongly hypercapnic and hypoxic) administered in a challenge paradigm, using a gas delivery setup designed for patient use. Cerebral blood flow mapping with arterial spin labeling, and simultaneous R 0 2 , R Ã 2 , and R 2 mapping with gradient-echo sampling of free induction decay and echo (GESFIDE) were performed. Reproducibility in air and gas-induced changes were evaluated using nonparametric analysis with correction for multiple comparisons. Results: Our gas delivery setup achieved stable gas challenges as shown by physiological monitoring. Test-retest variability of R 0 2 , R Ã 2 , and R 2 were found to be 0.24 s 21 (8.6% of mean), 0.24 s 21 (1.3% of mean), and 0.15 s 21 (1.0% of mean), respectively. Strong hypoxia produced the most conclusive oxygenation-driven relaxation change, inducing increases in R 0 2 (25 6 13%, P 5 0.03), R Ã 2 (5 6 2%, P 5 0.02), and R 2 (2 6 2%, NS). Conclusion: We benchmarked the intra-scan test-retest variability in GESFIDE-based transverse relaxation rate mapping. Using a reliable framework for gas challenge paradigms, we recommend strong hypoxia for validating oxygenation mapping methods, and the use of tissue R ). These relaxation rates are sensitive to the susceptibility effect of paramagnetic deoxyhemoglobin within the imaging voxel, as described by the blood oxygenation level dependent (BOLD) principle.
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Due to the relative simplicity of measuring R Ã 2 , it is the most common relaxation rate marker for susceptibility changes in tissues. Several studies have used R Ã 2 mapping to study brain tissue oxygenation changes in cerebrovascular pathologies, [7] [8] [9] although comparison against positron emission tomography did not find a relationship between abnormal oxygen metabolism and increased R Blood R 2 is also used to measure oxygenation in the brain, 12 although measurement of localized tissue R 2 13 is relatively limited, partly because it is affected by factors unrelated to oxygenation, including vasogenic edema, 14 gliosis, 15 and blood compartment changes. 16 In theory, R 0 2 is independent of these factors and has been proposed as a better measure of tissue susceptibility changes due to oxygenation.
In this study, we aimed to concurrently assess the intra-scan air-breathing reproducibility of tissue R 0 2 , R Ã 2 , and R 2 in the human brain, and to quantify changes in these parameters when the subject is breathing different strengths of hypercapnic and hypoxic gases. Based on our results, we aimed to ascertain which relaxation parameter is most suitable for imaging brain oxygenation, both in terms of the magnitude and polarity of changes observed during gas challenges, and whether the changes can be definitively attributed to oxygenation and perfusion.
MATERIALS AND METHODS

Subject Population
With approval from Stanford University's Institutional Review Board, 48 normal volunteers (25 male; ages 33 6 6 years; 23 female; ages 36 6 10 years) were scanned in this prospective study with informed consent and HIPAA compliance. All were screened for history of cerebrovascular disease, anemia, heart disease, or lung diseases that might affect blood and brain oxygenation. Volunteers were instructed to abstain from consuming caffeine for 12 h before the scan, given the known effects of caffeine on cerebral blood flow (CBF). 18 Volunteers were not instructed to abstain from smoking before the scan, although all scans took place on a tobacco-free campus.
Imaging Protocol
All subjects were scanned at 3.0T (MR750, GE Healthcare, Waukesha, WI). The imaging protocol consisted of three identical epochs (denoted as "Air 1", "Air 2", and "Gas" in Fig. 1 ). Air 1 and Air 2 epochs were performed consecutively during air breathing, while the Gas epoch followed a transition period of 2-3 min after commencing gas breathing, to ensure stable gas environment and subject physiology. Each epoch included measurements of oxygenation-driven relaxation and CBF as described below.
Imaging Sequences
At the start of the experiment, axial T 1 -weighted 3D SPGR BRA-VO images (TR/TE/TI 9.2/3.7/400 ms, flip angle 13 8, voxel size 0.9 3 0.9 3 1.2 mm 3 ) were acquired for anatomic imaging and segmentation. At the start of each epoch, quadratic shim was performed to optimize magnetic field homogeneity, so that detected variation in relaxation rate can be attributed to intrinsic changes in tissue susceptibility. Each epoch consisted of two sequences. Relaxometry was performed using the massively multi-echo two-dimensional (2D) gradient echo sampling of free induction decay echoes (GESFIDE) sequence (Fig. 2) , 19 Initial anatomical imaging was performed using a T 1 -weighted brain volume (BRAVO) sequence. During initial air breathing, reproducibility of oxygenation (measured using 2D GESFIDE) and CBF (using ASL) was performed in succession to test reproducibility. Following this, one of four gases was administered to perturb oxygenation, and following a 2-to 3-min period to allow brain oxygenation levels to stabilize, a final set of oxygenation and CBF imaging was performed. At the start of each epoch, high-order quadratic shimming was performed to minimize extrinsic susceptibility effects.
10% carbon dioxide, and 69% nitrogen; (4) Mild hypoxia: 14% oxygen and 86% nitrogen; and (5) Strong hypoxia: 10% oxygen and 90% nitrogen. Our gas delivery setup prioritized comfort and safety, and was implemented based on its feasibility for in-clinic use in future studies. Compressed medical air and one of the four gases were delivered at approximately 12 L/min by means of a bubble humidifier (Hudson RCI, Teleflex Inc., Research Triangle Park, NC) and standard oxygen therapy tubing to each subject, using an MR-safe high oxygen delivery face mask (Ceretec Hi-Ox, Ceretec Inc., Garden Grove CA), as shown in Figure 3 . A sampling nasal cannula (4000F, Salter Labs, Arvin, CA) was worn under the mask. A custom elastic strap ( Fig. 3 ) with quick-release buckles was worn during scan. As expected, leakage occurred and was dependent on subjects' facial geometry. In addition, for subject comfort and safety, we used a mask with an anti-suffocation valve, which entrained room air if the subject emptied the reservoir bag during deep inhalation or hyperventilation.
Physiological Monitoring
Extensive physiological recording was performed, including inspired and end-tidal oxygen fractional concentration and carbon dioxide partial pressure (f in O 2 , f et O 2 , P in CO 2 , and P et CO 2 ) by means of nasal cannula, heart rate, and peripheral oxygen saturation (S p O 2 ) by means of fingertip photoplethysmography, and systolic, diastolic, and mean arterial pressure from a brachial blood pressure cuff. All measurements were recorded by a medical monitor (Medrad Veris 8600, Bayer Healthcare, Whippany, NJ) at 1-s intervals.
Data Analysis
All data analysis was performed using custom Matlab (MathWorks Inc., Natick, MA) code, including functions from SPM8 (Wellcome Trust Centre for Neuroimaging, United Kingdom) and FSL (Oxford Centre for Functional MRI of the Brain, United Kingdom) software packages. To avoid introducing errors through coregistration, all GESFIDE images were analyzed in their native space, with T 1 -weighted anatomical images co-registered (using SPM8) to each GESFIDE dataset before undergoing segmentation (using FSL) into three regions of interest (ROIs): gray matter (GM), white matter (WM), and cerebrospinal fluid (CSF). pcASL images and CBF maps automatically generated 20 by the scanner (MR750, GE Healthcare, Waukesha, WI) were also co-registered to corresponding GESFIDE datasets. R 0 2 and R 2 maps were calculated from GESFIDE images using mono-exponential fitting of echoes from the "A" and "B" portions of the time curve illustrated in Figure 2 , as per the standard GESFIDE method for R 0 2 mapping. 19 R Ã 2 was calculated from the "A" portion. Intra-scan reproducibility of oxygenation-driven relaxation and CBF measurements was evaluated from the two air epochs, and assumed to be applicable to gas breathing. Datasets were excluded from analysis if at least one GESFIDE dataset from an air epoch displayed noticeable motion artifact, which manifested as Gibbs ringing or noticeable low-spatial frequency R2' variations in a pattern (e.g., bands) that did not correspond to anatomy.
Statistical Analysis
Wilcoxon signed-rank test was used to test for significance in changes in all physiological and imaging measurements between epochs, such as between first and second air epochs, or between air and gas epochs. Wilcoxon rank-sum test was used in pairwise comparisons between gas groups. Multiple comparisons were corrected using the Holm-Bonferroni method, which controls family-wise error rate. The significance level of 0.05 was used for all tests. For reproducibility analysis, agreement between the medical air epoch measurements was measured using Lin's concordance correlation coefficient q c 21 and Bland-Altman analysis.
RESULTS
Subject Population
Several datasets with motion artifacts were discarded. The final dataset consisted of 38 subjects (18 male, ages 34 6 7 years; 20 female, ages 34 6 9 years) for intra-scan reproducibility analysis, and 40 subjects (21 male; ages, 33 6 7 years; 19 female; ages, 34 6 9 years) for gas challenge analysis. Among reproducibility analysis datasets, five subjects were discarded as they were scanned on an outdated protocol with only one air epoch, and five others were discarded due to motion artifact during at least one air epoch. Among gas challenge datasets, eight from the following groups had motion artifacts that visibly corrupted the images: mild hypoxia (two subjects), strong hypercapnia (three subjects), and strong hypoxia (three subjects).
Gas Challenge Setup
Real-time recordings of S p O 2 , P in CO 2 , f in O 2 , P et CO 2 , and f et O 2 show that both normoxia and normocapnia were sustained during the air epochs, and that stable hypercapnia and hypoxia were indeed achieved during gas challenges ( Fig. 4 and Supplementary Fig. S1 , which is available online). As expected, measured f in O 2 and P in CO 2 deviated from the administered gas mixtures due to room air entrainment. Therefore, the achieved changes in end-tidal gas content were lower than expected for the gas mixtures: DP et CO 2 of 10 6 3 mmHg (sHC) and 7 6 4 mmHg (mHC), and DS p O 2 of 26 6 3% (mHO) and 211 6 3% (sHO). Recordings of heart rate, respiratory rate, and blood pressure also confirm that subject physiology was stable during air breathing, and changed in a consistent and expected manner during gas challenges (Fig. 4 and Supplementary  Fig. S1 ). Pairwise comparisons of changes in physiological measurements were performed between the four gas conditions (Table 1) . Notable findings include: (1) Df et O 2 was the only physiological change that significantly (P < 0.05) differentiated all pairs of groups, indicating its sensitivity to both hypercapnic and hypoxic challenges; (2) strong hypercapnia more significantly increased heart rate and diastolic blood pressure compared with other challenges. Full results are shown in Table 1 .
Reproducibility CBF was highly reproducible (Fig. 5) , with Lin's concordance correlation coefficient q c of 0.95 in GM and 0.93 in WM. Among the relaxation rates, R Ã 2 and R 2 had very high reproducibility (Fig. 5) , with q c > 0.90 for GM and WM. R 0 2 had lower correlation (q c 5 0.69 and 0.81 in GM and WM, respectively). The test-retest (Air 2 minus Air 1) differences between the two scans had overall standard deviation 3.6 mL/min/100 g or 6.7% (of mean value) for CBF, 0. 2 , showed significant change (P < 0.01 for both) between the air epochs, although the changes were extremely small (20.3% for f et O 2 and 10.2 mmHg for P et CO 2 ), and is a result of the small FIGURE 4: Changes in physiological measurements due to each gas challenge: strong hypercapnia (sHC), mild hypercapnia (mHC), mild hypoxia (mHO), and strong hypoxia (sHO).
variances due to the stable gas environment that allowed detection of these minimal changes. A full summary is presented in Supplementary Table 1.
Gas Challenges
Robust and significant (P 5 0.03) CBF increases were observed during hypercapnic challenges (Table 2 ). In GM, strong hypercapnia augmented CBF by 21 6 12%, and mild hypercapnia by 19 6 24%. We observed no significant change in CBF during hypoxia (3 6 5% with P 5 0.52 and 2 6 6% with P 5 1.00 in GM during mild and strong hypoxia, respectively). Changes in WM CBF were similar but had smaller mean and standard deviation compared with GM. Figure 6 illustrates two representative datasets during strong hypercapnia and hypoxia.
Gas-induced R 0 2 changes are shown in Figure 7 and Table 2 . In GM, the hypercapnic challenges did not show significant changes (sHC: DR 2 displayed expected polarities for both hypercapnic and hypoxic challenges, and was significant (P 5 0.02) for strong hypoxia. DR 2 had expected polarity and dose-dependent magnitude in all challenges, and was only significant (P 5 0.03 for both) in hypercapnia.
Relative percentage changes in measurements (denoted as %DCBF, %DR 0 2 , Table 2 ) show similar trends, but also shows that R Pairwise comparison was performed for each measurement between all gas challenges. In GM, notable findings include: (1) there was no statistically significant difference between strong and mild hypercapnia, or between strong and mild hypoxia, although DR2' magnitude suggested dose-dependence; (2) strong hypoxia induced a significant (P 5 0.01) increase in tissue DR All tests were corrected for multiple comparison using the Holm-Bonferroni method. b Indicates P < 0.05.
FIGURE 6: Representative datasets from strong hypercapnic (a) and strong hypoxic (b) gas challenges. Despite the low SNR of the GESFIDE datasets, we observe no reduction in R ' 2 despite CBF augmentation during hypercapnia, and elevation in R ' 2 with no change in CBF during hypoxia. differences between gas challenges. Also, for hypercapnia, changes in R Ã 2 were largely accounted for by changes in R 2 . Full results are shown in Table 3 .
DISCUSSION
This study successfully measured the intra-scan air-breathing reproducibility of CBF and all three transverse relaxation rates simultaneously, as well as the impact of different extents of hypercapnia and hypoxia on these measurements, using clinically friendly sequences and equipment. In doing so, we have produced valuable benchmarking information for future studies, supported some prior publications, and underlined many practical considerations in clinical applications.
Rigorous physiological monitoring in this study validated our gas challenge setup, which produced stable normoxic normocapnia and desired extents of hypercapnia and hypoxia. Intra-scan reproducibility studies indicate the minimum changes that can be confidently attributed to an external perturbation in an individual subject during a challenge experiment. During the air epochs, measured differences in CBF and relaxation parameters are attributed to fluctuations in unobserved physiological variables and noise from the imaging sequences. Our measured CBF variability was comparable to a previous study, 22 while there are no published simultaneous assessment of the reproducibility of these three transverse relaxation rates. Our GESFIDE relaxometry method fits R2* and R Ã 2 B from the measured signal curve, and then calculates R 0 2 and R 2 . As a result, fitting error is additively propagated to both R 0 2 and R 2 in identical ways. R 0 2 was found to have the lowest reproducibility, although we should note that ASL measurements of CBF had comparable variability.
In addition, absolute test-retest differences in R of R Ã 2 and R 2 . Moreover, despite our attempt to obtain a homogenous population by limiting enrolment to relatively young, normal volunteers, we also observed large inter-subject variation, which is also similar or lower than that of CBF measurements. Therefore, researchers investigating R 0 2 as a biomarker need to quantify and report reproducibility, and use intra-subject control data (e.g., contralateral measurements) wherever possible.
According to Yablonskiy and Haacke's quantitative BOLD (qBOLD) biophysical model, 23 R 0 2 is modeled as proportional to the product of deoxygenated blood volume (DBV) and SO 2 . Therefore, if we were to calculate SO 2 from independent measurements of R 0 2 and DBV, with intra-or inter-scan variability denoted by standard deviations dR 0 2 % and dDBV%, respectively, the corresponding variability in SO 2 will range between min{dR 0 2 , dDBV}% and (dR 0 2 1 dDBV)%. In other words, the intra-scan testretest difference of SO 2 calculated using GESFIDEmeasured R 0 2 will be at least 8.6% of the mean SO 2 measurement. dDBV may be approximated with dCBV, the variability of cerebral blood volume (CBV). In literature, intrascan test-retest dCBV has been measured to be around 22% in the whole brain for Dynamic Susceptibility Contrast (DSC) MRI at different field strengths, 24 and to be 4-5% 25 but regionally highly variable 26 for the noncontrast vascularspace-occupancy (VASO) method. Our measurements of hypercapnia-induced CBF increase were mostly consistent with values reported in literature, 22, 27, 28 although DCBF per mmHg of DP et CO 2 was unexpectedly lower in strong hypercapnia than in mild hypercapnia. On the other hand, prior studies reported a wide range of CBF changes in acute hypoxia, from small reductions to $20% increases. [29] [30] [31] In our work, we observed no significant CBF changes (P 5 0.05 and 1.00 for mild and strong hypoxia, respectively), possibly due to the short duration of hypoxia. During hypoxia, we observed positive and increasing DR 0 2 with increasing strength of challenge. This is consistent with theory. According to the BOLD principle, Yablonskiy and Haacke's biophysical model, 23 and the Grubb relation between CBF and CBV, 32 we expect R 0 2 to increase with CBF increase if SO 2 remains constant, and to increase with SO 2 decrease if CBF remains constant. Our observation was that the hypoxic challenge may have achieved the latter condition, where tissue SO 2 decreases due to reduction in oxygen supply without concomitant CBF change.
However, our hypercapnic data found no significant R 0 2 changes (all P > 0.05), possibly due to competing blood volume and oxygenation effects. During hypercapnia, CBF increases without any metabolic increases, leading to oversupply of oxygenated blood, increase in tissue SO 2 , and reduction in R Because hypercapnia produced opposing effects of increased SO 2 and increased blood volume, we believe that it is a suboptimal oxygenation challenge. An additional confounding factor is the Bohr effect during hypercapnia, where the lower pH would reduce SO 2 . Without blood sampling, we cannot quantify this competing effect. An alternative gas challenge for increasing tissue oxygenation is hyperoxia, which has been reported to cause insignificant reduction in CBF with appropriate T 1 correction for ASL-based measurements, 33 removing one of the opposing effects and resulting in a net R 0 2 reduction. We plan to test this challenge with our setup in the future.
Blood DR 2 also experiences these competing effects, 16 so we expect brain tissue DR 2 to face similar problems. Our tissue DR 2 measurements in hypercapnia suggest that DR 2 is more weighted by SO 2 change than DR 0 2 , but DR 2 in hypoxia was smaller than DR 0 2 despite the absence of blood volume change. This suggests that the oxygenation-based component of tissue R 2 has a more complicated model than R 0 2 . Due to the lack of theoretical foundation for tissue R 2 modeling, it is limited in utility. Additionally, due to the sensitivity of tissue R 2 to nonoxygenation factors, baseline R 2 is limited as a biomarker in the presence of pathology. Although this study is performed in normal volunteers, the findings contribute toward the knowledge base needed for translating relaxometry-based oxygenation mapping to patients.
By magnitude alone, DR Ã 2 is most sensitive, producing strongly polar responses to all four gas challenges. However, due to the dependence of DR Ã 2 (5DR 0 2 1 DR 2 ) on DR 2 , it is similarly poorly modeled and has limited utility in patients with brain pathologies.
Lastly, we note that percentage DR 0 2 was by far the largest during hypoxia. This suggests that relative R 0 2 change is potentially a good parameter for studying oxygenation changes in challenge paradigms where blood volume changes are either negligible or quantified to isolate the effect of oxygenation change. This is particularly true in focal changes, such as lesions in ischemic stroke, where pathology is likely to impact R 2 and, therefore, R Ã 2 . While we had a relatively large sample size, we did not perform multiple gas challenges in the same individual, so we cannot attribute inter-group differences to gas challenges alone. It is possible, although unlikely, that physiology of subjects could have been unbalanced at the group level, potentially confounding our results. We did not measure CBV change in this study, so we could not estimate its effect on spin relaxation. A noncontrast and, therefore, repeatable measurement of relative CBV is theoretically possible using the VASO technique. 34 In pathologies, tissue composition may also change, altering the baseline measurements of relaxation rates and potentially affecting the relaxation rate changes due to challenges. Therefore, separate CBV quantitation is crucial in pathologies. Additionally, in our study, we selected GESFIDE imaging parameters to prioritize high spatial resolution and short echo time spacing. The small voxel size resulted in low spatial SNR in the R 0 2 measurements, so that analysis was performed for large ROIs at group level, instead of voxel-wise in individual subjects, where imaging parameters would need to be optimized. Finally, we did not perform T 1 mapping or correction in calculating CBF from pcASL data during different gas epochs and across subjects. Various modeling and experimental studies [35] [36] [37] [38] have shown that blood T 1 is strongly dependent on hematocrit, weakly but nonnegligibly dependent on deoxyhemoglobin concentration, and strongly dependent on the amount of dissolved molecular oxygen (O 2 ). The lack of hematocrit correction in this study likely added noise to our results. Although the amount of dissolved O 2 is already low during air-breathing and would not be increased by either hypercapnia or hypoxia, the corresponding deoxyhemoglobin concentration changes may have biased the calculated CBF values. Specifically, during hypoxia, actual CBF may have been slightly higher than reported. This effect competes against the impact of decreasing oxygenation on transverse relaxation rates. In summary, this study used a reliable setup for gas challenge paradigms, assessed the intra-scan reproducibility of transverse relaxation rate measurements for the first time, and demonstrated changes in these parameters with hypercapnia and hypoxia in a large cohort. From our measurements, we recommend the use of strong hypoxia for studying oxygenation mapping methods in healthy volunteers over hypercapnia, which creates competing effects and potentially inconclusive measurements. We also recommend the use of R 0 2 change, over R Ã 2 or R 2 , for studying brain tissue oxygenation. Future studies should concentrate on improving R 0 2 mapping sequences to evaluate focal oxygenation changes in individuals. T1 quantification should also be performed for quantitative oxygenation studies involving ASL, relaxometry, and any strong gas challenge.
